<bill session="112" type="s" number="3232" updated="2012-11-24T17:36:49-05:00">
	<state datetime="2012-05-23">REFERRED</state>
	<status><introduced datetime="2012-05-23"/></status>

	<introduced datetime="2012-05-23"/>
	<titles>
		<title type="official" as="introduced">A bill to amend the Internal Revenue Code of 1986 and the Patient Protection and Affordable Care Act to extend, expand, and improve the qualifying therapeutic discovery project program.</title>
	</titles>
	<sponsor id="400272"/>
	<cosponsors>

	</cosponsors>
	<actions>
		<action datetime="2012-05-23" state="REFERRED"><text>Read twice and referred to the Committee on Finance.</text></action>
	</actions>
	<committees>
		<committee code="SSFI" name="Senate Finance" activity="Referral, In Committee" />
	</committees>
	<relatedbills>

	</relatedbills>
	<subjects>
		<term name="Taxation"/>
		<term name="Health programs administration and funding"/>
		<term name="Health promotion and preventive care"/>
		<term name="Income tax credits"/>
		<term name="Medical research"/>
	</subjects>
	<amendments>

	</amendments>
	<summary>
	5/23/2012--Introduced.
Amends the Internal Revenue Code and the Patient Protection and Affordable Care Act, with respect to the tax credit for the qualifying therapeutic discovery project program, to: (1) extend such credit and credit allocations through 2012; (2) increase the total amount of credits allocable to $2 billion for the 4-year period beginning with 2009; (3) extend from 30 to 90 days the period for review of applications for certification of investments under such program and the time for making payments to applicants; and (4) modify the criteria used by the Secretary of the Treasury for selecting program projects to require the selection of projects that show significant potential (currently, reasonable potential). 
	</summary>
</bill>
